<p>Human synovial fibroblasts were incubated with TNF-α (10 ng/ml) for indicated time intervals. mRNA and released IL-6 were determined by QPCR and ELISA respectively. Treatment with TNF-α enhanced the IL-6 mRNA (A) expression and cytokine release (B) in a time-dependent manner. Pretreatment with two 5-LOX inhibitors, NDGA (5 or 10 µM) or MK-886 (5 µM) for 1 hr significantly inhibited the TNF-α-induced mRNA (C) or protein levels (D) of IL-6. Data are presented as mean ± SEM. *, p<0.05 compared with vehicle control (con). #, p<0.05 compared with TNF-α treatment alone.</p
[Abstract] Introduction: The clinical efficacy of specific interleukin-6 inhibitors has confirmed th...
<p>(A) Total protein were extracted from normal synovial fibroblasts and OASFs, and subjected to wes...
Background/Purpose: Cytohistomorphological analysis of the synovial joint provides researchers with ...
<p>Total protein extracts from RASFs transfected with empty vector or 5-LOX shRNA were used for West...
<p>Human synovial fibroblasts were pretreated with NDGA (10 µM) or MK-886 (5 µM) for 1 hr, and then ...
<p>(A) Immunoblotting showed that treatment of TNF-α (10 ng/ml) enhanced the phosphorylation of IκBα...
<p>Human synovial fibroblasts were pretreated with LTB4 receptor antagonist LY29311 (1 µM) for 1 hr,...
<p>TNF-α increased the release of IL-6 and MCP-1 via the activation of NF-κB signaling in RASFs. 5-L...
The lipoxygenase isoform of 5-lipoxygenase (5-LOX) is reported to be overexpressed in human rheumato...
<div><p>The lipoxygenase isoform of 5-lipoxygenase (5-LOX) is reported to be overexpressed in human ...
The lipoxygenase isoform of 5-lipoxygenase (5-LOX) is reported to be overexpressed in human rheumato...
The lipoxygenase isoform of 5-lipoxygenase (5-LOX) is reported to be overexpressed in human rheumato...
<p>Soluble chimeric monoclonal anti-TNF-α antibody (infliximab) was added to the culture supernatant...
AbstractThe treatment of human diploid fibroblasts with tumor necrosis factor (TNP)-α and with lymph...
<p><b>A–B</b>. NPCs were treated with 20 ng/mL TNF-α for 4, 8, 24 and 72 h. mRNA expression of IL-6 ...
[Abstract] Introduction: The clinical efficacy of specific interleukin-6 inhibitors has confirmed th...
<p>(A) Total protein were extracted from normal synovial fibroblasts and OASFs, and subjected to wes...
Background/Purpose: Cytohistomorphological analysis of the synovial joint provides researchers with ...
<p>Total protein extracts from RASFs transfected with empty vector or 5-LOX shRNA were used for West...
<p>Human synovial fibroblasts were pretreated with NDGA (10 µM) or MK-886 (5 µM) for 1 hr, and then ...
<p>(A) Immunoblotting showed that treatment of TNF-α (10 ng/ml) enhanced the phosphorylation of IκBα...
<p>Human synovial fibroblasts were pretreated with LTB4 receptor antagonist LY29311 (1 µM) for 1 hr,...
<p>TNF-α increased the release of IL-6 and MCP-1 via the activation of NF-κB signaling in RASFs. 5-L...
The lipoxygenase isoform of 5-lipoxygenase (5-LOX) is reported to be overexpressed in human rheumato...
<div><p>The lipoxygenase isoform of 5-lipoxygenase (5-LOX) is reported to be overexpressed in human ...
The lipoxygenase isoform of 5-lipoxygenase (5-LOX) is reported to be overexpressed in human rheumato...
The lipoxygenase isoform of 5-lipoxygenase (5-LOX) is reported to be overexpressed in human rheumato...
<p>Soluble chimeric monoclonal anti-TNF-α antibody (infliximab) was added to the culture supernatant...
AbstractThe treatment of human diploid fibroblasts with tumor necrosis factor (TNP)-α and with lymph...
<p><b>A–B</b>. NPCs were treated with 20 ng/mL TNF-α for 4, 8, 24 and 72 h. mRNA expression of IL-6 ...
[Abstract] Introduction: The clinical efficacy of specific interleukin-6 inhibitors has confirmed th...
<p>(A) Total protein were extracted from normal synovial fibroblasts and OASFs, and subjected to wes...
Background/Purpose: Cytohistomorphological analysis of the synovial joint provides researchers with ...